Trial intelligence / Profile preview

Pioglitazone in ulcerative colitis

IRCT201103035867N2Phase 2Completed

Sponsor
Tehran University of Medical Sciences
Start
Jun 2010
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised trial of pioglitazone in autoimmune colitis (2 arms), sponsored by Tehran University of Medical Sciences. Started Jun 2010; status: completed.

02

Drugs

pioglitazone
03

Conditions

autoimmune colitis

Beyond the preview

Go deeper on IRCT201103035867N2.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT201103035867N2.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call